Specially engineered 'young' immune cells could help to reverse the effects of aging and the damage to brain cells caused by ...

IgE, best known for mediating allergic reactions, may also shape cancer outcomes. Learn how this immune molecule could serve as both a biomarker and a basis for next-generation therapies.

Black survivors of multiple myeloma say the latest developments in treatment give them hope even as federal research cuts ...

Capturing and testing cancer cells from a patient’s blood may help doctors personalize breast cancer treatment, reducing ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces clinical data for CT0596, an allogeneic BCMA-targeting CAR-T ...

Bacterial metabolites queuine and preQ1 have been found to directly regulate protein synthesis in human cells, promoting or ...

Injecting poly-ICLC directly into prostate tumors before surgery may reawaken immune activity and help transform resistant ...

The woman posted a marriage ad seeking a terminally-ill man to receive his kidney posthumously. Their initial survival pact ...

NEXICART-2 (NCT06097832) is an ongoing multi-site U.S. Phase 1/2 clinical trial of sterically-optimized CAR-T NXC-201 in relapsed/refractory AL Amyloidosis, with a registrational design. Interim ...

Inflammatory arthritis resulting from immune checkpoint inhibitor use is immunologically unique and likely driven by T cells ...